Literature DB >> 23399375

The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies.

Ronald Klein1, Karen J Cruickshanks, Chelsea E Myers, Theru A Sivakumaran, Sudha K Iyengar, Stacy M Meuer, Carla R Schubert, Ronald E Gangnon, Barbara E K Klein.   

Abstract

OBJECTIVE: To describe the relationships of intima-media thickness (IMT), plaque in the carotid artery, angina, myocardial infarction (MI), and stroke to the 10-year cumulative incidence of early and late age-related macular degeneration (AMD) and progression of AMD.
DESIGN: Cohort study. PARTICIPANTS: A total of 1700 persons aged 53 to 96 years who participated in both the Epidemiology of Hearing Loss Study and the Beaver Dam Eye Study in 1998-2000, with photographs gradable for AMD at 5-year (2003-2005) and 10-year (2008-2010) follow-up examinations.
METHODS: The IMT and presence of plaque were assessed using B-mode ultrasonography of the carotid artery. Presence of angina, MI, and stroke were defined on the basis of a self-reported history of physician diagnosis. The presence and severity of AMD were determined by systematic grading of stereoscopic color fundus photographs. MAIN OUTCOME MEASURES: Age-related macular degeneration.
RESULTS: The 10-year cumulative incidence of early AMD was 15.7%, and the 10-year cumulative incidence of late AMD was 4.0%. After adjusting for age, sex, body mass index, smoking status, age-related maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) genotypes, and other factors, mean IMT was associated with the 10-year incidence of early AMD (odds ratio [OR] per 0.1 mm IMT, 1.11; 95% confidence interval [CI], 1.00-1.21; P = 0.03) and late AMD (OR per 0.1 mm IMT, 1.27; CI, 1.10-1.47; P = 0.001). Mean IMT was associated with the 10-year incidence of pure geographic atrophy (OR per 0.1 mm IMT, 1.31; CI, 1.05-1.64; P = 0.02) but not exudative AMD (OR per 0.1 mm IMT, 1.14; CI, 0.97-1.34; P = 0.11). Similar associations were found for maximum IMT. The number of sites with plaque was related to the incidence of late AMD (OR per 0.1 mm IMT, 2.79 for 4-6 sites vs. none; CI, 1.06-7.37; P = 0.04) but not to early AMD. A history of angina, MI, or stroke was not related to any incident AMD outcome.
CONCLUSIONS: In these population-based data, carotid artery IMT and carotid plaques had a weak relationship to the incidence of late AMD that was independent of systemic and genetic risk factors. Angina, MI, and stroke were not related to AMD. It is unclear whether the carotid IMT is a risk indicator of processes affecting Bruch's membrane and the retinal pigment epithelium, or a measure of atherosclerosis affecting susceptibility to AMD. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23399375      PMCID: PMC3646961          DOI: 10.1016/j.ophtha.2012.11.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  41 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Reduced foveolar choroidal blood flow in eyes with increasing AMD severity.

Authors:  Juan E Grunwald; Tatyana I Metelitsina; Joan C Dupont; Gui-Shuang Ying; Maureen G Maguire
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

3.  Foveolar choroidal blood flow in age-related macular degeneration.

Authors:  J E Grunwald; S M Hariprasad; J DuPont; M G Maguire; S L Fine; A J Brucker; A M Maguire; A C Ho
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-02       Impact factor: 4.799

4.  The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

5.  Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

Authors:  W Smith; P Mitchell; S R Leeder; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-05

6.  Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study.

Authors:  R Klein; L Clegg; L S Cooper; L D Hubbard; B E Klein; W N King; A R Folsom
Journal:  Arch Ophthalmol       Date:  1999-09

Review 7.  Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Am J Epidemiol       Date:  1998-01-15       Impact factor: 4.897

8.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

9.  Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study.

Authors:  Michael D Knudtson; Barbara E K Klein; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2006-02

10.  Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study.

Authors:  J R Vingerling; I Dielemans; M L Bots; A Hofman; D E Grobbee; P T de Jong
Journal:  Am J Epidemiol       Date:  1995-08-15       Impact factor: 4.897

View more
  15 in total

Review 1.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

2.  The relationships between the pulsatile flow form of ocular microcirculation by laser speckle flowgraphy and the left ventricular end-diastolic pressure and mass.

Authors:  Tomoaki Shiba; Mao Takahashi; Chieko Shiba; Tadashi Matsumoto; Yuichi Hori
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-01       Impact factor: 2.357

Review 3.  Clinical characteristics and current treatment of age-related macular degeneration.

Authors:  Yoshihiro Yonekawa; Ivana K Kim
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-03       Impact factor: 6.915

Review 4.  Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.

Authors:  Mayur Choudhary; Goldis Malek
Journal:  J Biomol Screen       Date:  2016-07-28

Review 5.  Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium.

Authors:  Ronald Klein; Chelsea E Myers; Gabriëlle H S Buitendijk; Elena Rochtchina; Xiaoyi Gao; Paulus T V M de Jong; Theru A Sivakumaran; George Burlutsky; Roberta McKean-Cowdin; Albert Hofman; Sudha K Iyengar; Kristine E Lee; Bruno H Stricker; Johannes R Vingerling; Paul Mitchell; Barbara E K Klein; Caroline C W Klaver; Jie Jin Wang
Journal:  Am J Ophthalmol       Date:  2014-05-28       Impact factor: 5.258

Review 6.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

7.  Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study.

Authors:  Layal Chaker; Gabriëlle H S Buitendijk; Abbas Dehghan; Marco Medici; Albert Hofman; Johannes R Vingerling; Oscar H Franco; Caroline C W Klaver; Robin P Peeters
Journal:  BMC Med       Date:  2015-04-23       Impact factor: 8.775

Review 8.  Inflammation and its role in age-related macular degeneration.

Authors:  Anu Kauppinen; Jussi J Paterno; Janusz Blasiak; Antero Salminen; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2016-02-06       Impact factor: 9.261

9.  Sensory Impairments and Risk of Mortality in Older Adults.

Authors:  Carla R Schubert; Mary E Fischer; A Alex Pinto; Barbara E K Klein; Ronald Klein; Ted S Tweed; Karen J Cruickshanks
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-05-01       Impact factor: 6.053

Review 10.  Age-Related Macular Degeneration: Advances in Management and Diagnosis.

Authors:  Yoshihiro Yonekawa; Joan W Miller; Ivana K Kim
Journal:  J Clin Med       Date:  2015-02-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.